Did you miss one of our webinars? Simply select the appropriate link below and view the recorded webinar. It will not be interactive, but you will see the chat questions the original attendees asked. For additional information on the products discussed in the webinar, explore our links to videos and other resources.
If there is an area you would like to see covered, you can request a topic of your choice.
If you are experiencing issues opening the webinar recordings, please be sure that you have the latest Adobe Flash Player installed.
Please select a webinar type
Cell-Based Assays
Drug Discovery
Genetic Identity
Genomics
Life Science
Molecular Diagnostics (MDx)
Proteomics
Cell-Based Assays
Tuesday, November 14, 2017
Terry Riss, PhD
With traditional cell-based endpoint assays you can miss important cellular events if measurement isn't taken at the appropriate time, particularly when characterizing a compound's effect on cells. Additionally, assay reagents can negatively affect cell health and endpoint assays can impede downstream multiplexing.
Cell-Based Assays
Tuesday, October 24, 2017
Marie Schwinn, PhD
CRISPR/Cas9 gene editing has emerged as a powerful tool for making precise genomic modifications. Although often used to create gene knockouts, the technology also enables targeted knock-in of a specific sequence. An exciting application is the endogenous tagging of proteins expressed under native regulatory conditions. In this webinar, we will detail a simple and efficient cloning-free method for CRISPR-mediated endogenous gene tagging, focusing on knock-in of the sensitive, bioluminescent HiBiT tag.
Genomics
Tuesday, October 10, 2017
Charles Cowles, PhD
Current size-selective DNA purification methods need improvement with respect to sample loss, poor reproducibility, high viscosity and recovery of undesired high MW fragments. With new size selection chemistry, you can improve yield, selectivity, usability, and functionality in NGS library cleanup and size selection, as well as PCR cleanup and other applications.
Cell-Based Assays
Tuesday, September 26, 2017
Christopher Eggers, PhD
Regulated protein abundance and surface expression are fundamental to normal cellular physiology and dysregulation underlies many disease states. Monitoring changes in protein abundance usually involves labor-intensive, antibody-based methods that yield only semi-quantitative results. This webinar will introduce a bioluminescent tagging system that can quantify proteins in minutes using simple, antibody-free methods. This system offers wide dynamic range and sensitivity compatible with detecting even endogenously expressed proteins when combined with CRISPR gene editing.
Drug Discovery
Tuesday, September 19, 2017
Ulrike Herbrand, PhD
In past years, the requirement for bioactivity testing changed from later phase lot release and stability testing to additional applications like biocomparability testing for follow-on biologics, accelerated stress condition testing and confirmation of successful production scale up. Therefore a suitable bioassay is needed at a very early time point. This webinar will look at a wide variety of therapeutic proteins and illustrate some best practices in method development that results in reliable, reproducible and precise assays, and discuss which assays may be best for your product and development program.
